NCS Multistage (NCSM) awards director 3,221 restricted stock units

Rhea-AI Filing Summary

RALLS W MATT reported acquisition or exercise transactions in this Form 4 filing.

NCS Multistage Holdings director W. Matt Ralls received a grant of 3,221 shares of common stock in the form of restricted stock units at a price of $0.00 per share. These units vest on February 28, 2027.

After this award, he holds 31,065 shares directly, including 3,221 unvested restricted stock units and 25,256 vested restricted stock units that will be settled in shares within thirty days after the earlier of his service ending for any reason or a change of control.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider RALLS W MATT

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,221	$0.00	--

Holdings After Transaction: Common Stock — 31,065 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RALLS W MATT

(Last) (First) (Middle)

C/O NCS MULTISTAGE HOLDINGS, INC.

19350 STATE HIGHWAY 249, SUITE 600

(Street)

HOUSTON TX 77070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NCS Multistage Holdings, Inc. [ NCSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		3,221	A	$0	31,065(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 3,221 restricted stock units which vest on February 28, 2027 and 25,256 vested restricted stock units and and all of which settle within thirty days following the earlier of (i) the termination of the Reporting Person's service for any reason or (ii) a change of control.

	/s/ Ori Lev, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NCS Multistage (NCSM) report for W. Matt Ralls?

NCS Multistage reported that director W. Matt Ralls received 3,221 restricted stock units of common stock as a grant at a price of $0.00 per share. This non-cash award increases his directly held position to 31,065 shares after the transaction.

When do the newly granted restricted stock units for NCSM’s director vest?

The 3,221 newly granted restricted stock units to NCSM director W. Matt Ralls vest on February 28, 2027. Vesting means the units become earned at that date, though actual share settlement follows specific service termination or change-of-control conditions described in the award terms.

How many NCS Multistage (NCSM) shares does W. Matt Ralls hold after this Form 4?

After this award, W. Matt Ralls holds 31,065 NCS Multistage common shares directly. This total includes 3,221 unvested restricted stock units and 25,256 vested restricted stock units, which are scheduled to settle in shares under the specified service and change-of-control conditions.

What are the settlement terms for W. Matt Ralls’ restricted stock units at NCSM?

All of W. Matt Ralls’ restricted stock units settle in shares within thirty days after the earlier of two events: the termination of his service for any reason or a change of control at NCS Multistage. This applies to both vested and the newly granted units.

Was there any cash paid for the NCS Multistage (NCSM) stock units granted to the director?

No cash changed hands for this grant. The 3,221 restricted stock units of NCS Multistage common stock were awarded at a transaction price of $0.00 per share, reflecting a stock-based compensation grant rather than an open-market purchase.